Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven van Laecke

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Nature Reviews. Nephrology|April 17, 2024
Thiazides in kidney transplant recipients: skin in the gameSteven Van Laecke
Nature Reviews. Nephrology|August 31, 2019
Lipid lowering and risk of haemorrhagic stroke in CKDSteven Van Laecke
Acta Clinica Belgica|September 18, 2018
Hypomagnesemia and hypermagnesemiaSteven Van Laecke
Hypertension (Dallas, Tex. : 1979)|June 15, 2011
Magnesium and vascular dysfunction in malignant hypertensionSteven Van Laecke, Raymond Vanholder
The New England Journal of Medicine|November 4, 2011
Bardoxolone methyl, chronic kidney disease, and type 2 diabetesSteven Van Laecke, Raymond Vanholder
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 8, 2019
Cardiovascular disease in kidney transplant recipients: leave no stone unturnedSteven Van Laecke, Daniel Abramowicz
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 10, 2024
Terminally differentiated effector memory T cells in kidney transplant recipients: New crossroadsSteven Van Laecke, Griet Glorieux
Transplantation|August 6, 2010
The metabolic syndrome and new-onset diabetes after transplantation: presumed guilty?Steven Van Laecke, Raymond Vanholder
The Lancet. Diabetes & Endocrinology|December 25, 2016
Type 2 diabetes: a two-headed snake in kidney transplant recipients?Steven Van Laecke, Raymond Vanholder
Transplantation Reviews (Orlando, Fla.)|May 24, 2015
Hypomagnesaemia in kidney transplantationSteven Van Laecke, Wim Van Biesen
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Nature Reviews. Nephrology|April 17, 2024
Thiazides in kidney transplant recipients: skin in the gameSteven Van Laecke
Nature Reviews. Nephrology|August 31, 2019
Lipid lowering and risk of haemorrhagic stroke in CKDSteven Van Laecke
Acta Clinica Belgica|September 18, 2018
Hypomagnesemia and hypermagnesemiaSteven Van Laecke
Hypertension (Dallas, Tex. : 1979)|June 15, 2011
Magnesium and vascular dysfunction in malignant hypertensionSteven Van Laecke, Raymond Vanholder
The New England Journal of Medicine|November 4, 2011
Bardoxolone methyl, chronic kidney disease, and type 2 diabetesSteven Van Laecke, Raymond Vanholder
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 8, 2019
Cardiovascular disease in kidney transplant recipients: leave no stone unturnedSteven Van Laecke, Daniel Abramowicz
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 10, 2024
Terminally differentiated effector memory T cells in kidney transplant recipients: New crossroadsSteven Van Laecke, Griet Glorieux
Transplantation|August 6, 2010
The metabolic syndrome and new-onset diabetes after transplantation: presumed guilty?Steven Van Laecke, Raymond Vanholder
The Lancet. Diabetes & Endocrinology|December 25, 2016
Type 2 diabetes: a two-headed snake in kidney transplant recipients?Steven Van Laecke, Raymond Vanholder
Transplantation Reviews (Orlando, Fla.)|May 24, 2015
Hypomagnesaemia in kidney transplantationSteven Van Laecke, Wim Van Biesen
Pageof 9